Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
56.19
-0.09 (-0.16%)
At close: Jun 27, 2025, 4:00 PM
56.19
0.00 (0.00%)
After-hours: Jun 27, 2025, 4:06 PM EDT
Akero Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$82.50
Upside
+46.82%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $63 → $64 | Strong Buy | Maintains | $63 → $64 | +13.90% | May 27, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $80 → $78 | Strong Buy | Maintains | $80 → $78 | +38.81% | May 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $72 → $75 | Strong Buy | Maintains | $72 → $75 | +33.48% | Mar 3, 2025 |
| UBS | UBS | Strong Buy Maintains $42 → $109 | Strong Buy | Maintains | $42 → $109 | +93.98% | Jan 31, 2025 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $35 → $63 | Hold → Strong Buy | Upgrades | $35 → $63 | +12.12% | Jan 30, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $46 → $96 | Buy | Maintains | $46 → $96 | +70.85% | Jan 28, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $65 → $80 | Strong Buy | Maintains | $65 → $80 | +42.37% | Jan 28, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $56 → $73 | Strong Buy | Maintains | $56 → $73 | +29.92% | Jan 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $72 | Strong Buy | Maintains | $50 → $72 | +28.14% | Jan 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | -11.02% | Jan 16, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | +15.68% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | -11.02% | Nov 18, 2024 |
| B of A Securities | B of A Securities | Hold Maintains $30 → $35 | Hold | Maintains | $30 → $35 | -37.71% | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | -11.02% | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | -11.02% | Sep 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | -11.02% | Aug 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.